ALDX 241220 2.50P (ALDX241220P2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

ALDX241220P2500

Watchlist

0.10
0.000.00%

15min DelayTrading Nov 13 10:46 ET

0.00High0.00Low

Intraday

5D
Daily

News

Oppenheimer Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Raises Target Price to $12
Moomoo NewsDec 16 08:31 ET · Ratings
Analysts' Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Keros Therapeutics (KROS)
TipRanksDec 16 07:50 ET · Ratings
Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?
Zacks Dec 9 09:15 ET
Positive Outlook for Aldeyra Therapeutics: Buy Rating Backed by Promising Reproxalap Prospects and Strategic Partnership With AbbVie
TipRanksDec 9 06:32 ET · Ratings
Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference
Aldeyra TherapeuticsDec 2 00:00 ET
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Zacks Nov 19 09:35 ET

Comments

sharphooks

Nov 20 16:25

$Aldeyra Therapeutics (ALDX.US)$ wonder why this stock hasn't done better with the good news ?

frogoracletrading

Oct 3 08:17

$ALDX Support / Resistance Levels

Here are the levels on ALDX.
Larger Image: tradingview.com...
$Aldeyra Therapeutics (ALDX.US)$

Trytosaveabit

Aug 8 06:22

A bit more!

$Aldeyra Therapeutics (ALDX.US)$ Aldeyra Therapeutics Achieves Primary Endpoint In Phase 3 Trial For Reproxalap Ophthalmic Solution In Treating Dry Eye Disease; Statistically Superior For Ocular Discomfort; NDA Resubmission Anticipated In 2024

Trytosaveabit

Aug 8 06:17

Resume quotes at 7:25AM and Trade at 7:30AM est

$Aldeyra Therapeutics (ALDX.US)$ 🤫

Trytosaveabit

Aug 8 06:06

Update

$Aldeyra Therapeutics (ALDX.US)$ Aldeyra: No Safety Signals Observed in Clinical Trial, and Reproxalap Was Observed to Be Well Tolerated